Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Nabriva Therapeutics revenue
Nabriva Therapeutics's revenue is $12.0 million.
What is Nabriva Therapeutics's revenue?
- Nabriva Therapeutics has 175 employees, and the revenue per employee ratio is $68,571.
- Nabriva Therapeutics peak revenue was $12.0M in 2024.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Nabriva Therapeutics financing
Nabriva Therapeutics received early financing of $10.0M on 2015-12-23.
| Series | Round size | Date |
|---|---|---|
| Series Unknown | $10M | 12/2015 |
| Series A | $45M | 03/2016 |
| Debt Financing | $10M | 09/2016 |
Nabriva Therapeutics investors
| Investors | Security type |
|---|---|
| Square 1 Bank | Series Unknown |
| Frazier Healthcare Partners | Series A |
| Longitude Capital | Series A |
| Aisling Capital | Series A |
| Square 1 Bank | Debt Financing |
Nabriva Therapeutics competitors
Nabriva Therapeutics's top competitor, Spero Therapeutics, earned an annual revenue of $48.0M.
Nabriva Therapeutics's smallest competitor is Onconova Therapeutics with revenue of $226.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Spero Therapeutics | - | $48.0M | 41 | - |
| Cerexa Inc. | - | $1.3M | 29 | - |
| Leap Therapeutics | - | $1.5M | 30 | - |
| Onconova Therapeutics | - | $226,000 | 12 | - |
| Aclaris Therapeutics | - | $18.7M | 60 | - |
| XOMA | - | $28.5M | 11 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Most in demand jobs
Zippia gives an in-depth look into the details of Nabriva Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Nabriva Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Nabriva Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Nabriva Therapeutics. The data presented on this page does not represent the view of Nabriva Therapeutics and its employees or that of Zippia.
Nabriva Therapeutics may also be known as or be related to Nabriva Therapeutics plc,, Nabriva Therapeutics PLC and Nabriva Therapeutics.